Share Email Print
cover

Proceedings Paper

In-vivo autofluorescence spectroscopy of bladder carcinoma with a mercury arc lamp
Author(s): Marie-Ange D'Hallewin; Luc Baert; Herman A. Vanherzeele
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Bladder tissue autofluorescence spectra are obtained in vivo at two excitation wavelengths (334 nm and 365 nm) with a cystoscopic fiber- optic device based on a small mercury arc lamp. Upon 365 nm excitation, both normal and cancerous bladder tissue have nearly identical fluorescence spectra, characterized by a broad peak at 455 nm. However, the fluorescence yield from malignant tissue is approximately a factor 3 lower compared to normal tissue. A similar decrease in fluorescence yield is observed upon 334 nm excitation. More importantly, at this excitation wavelength, the spectra from normal and malignant tissue have different lineshape. Normal tissue shows two distinct fluorescence peaks (at 385 nm and 455 nm), while malignant tissue only shows the 455 nm peak. Based on these insights, we have developed a simple spectroscopic algorithm, to differentiate normal from malignant bladder tissue with our device. The main underlying biophysics will be addressed. The integration of the diagnostic method with a reliable therapeutic technique for tumor cell destruction, may open the way for cost- effective preventive care of high-risk patients.

Paper Details

Date Published: 12 April 1995
PDF: 6 pages
Proc. SPIE 2387, Advances in Laser and Light Spectroscopy to Diagnose Cancer and Other Diseases II, (12 April 1995); doi: 10.1117/12.206807
Show Author Affiliations
Marie-Ange D'Hallewin, Katholieke Univ. Leuven (Belgium)
Luc Baert, Katholieke Univ. Leuven (Belgium)
Herman A. Vanherzeele, Vrije Univ. Brussels (Belgium)


Published in SPIE Proceedings Vol. 2387:
Advances in Laser and Light Spectroscopy to Diagnose Cancer and Other Diseases II
Robert R. Alfano, Editor(s)

© SPIE. Terms of Use
Back to Top